Please click on their logos to visit their websites for further information.
Hologic is an innovative medical technology company that enables healthier lives everywhere, every day.
We are also a company that prospers and grows, which is why we’ve been able to expand our offerings to empower even more people and champion women’s health.
What powers our growth across Breast & Skeletal Health, Diagnostics and GYN Surgical is also what differentiates us: the exceptional and clinically proven capacity of our products to detect, diagnose and treat illnesses and other health conditions earlier and better. This clinical superiority creates high expectations, which we fulfil by continually challenging ourselves to improve health through better technology, education and market access.
The world leader in mammography, Hologic has expanded its product portfolio significantly through insight-driven innovation and strategic acquisitions to address the entire clinical continuum of breast cancer diagnosis and care. From digital specimen radiography and stereotactic breast biopsy systems, to breast biopsy markers and surgical guidance systems. Hologic’s comprehensive suite of products is designed to meet the unmet and changing needs of patients and clinicians.
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy.
Designed to improve patient outcomes, the SCOUT® Radar Localization system represents Merit Oncology's strong commitment to reducing the burden of breast cancer on patients and their loved ones.
The SCOUT® Radar Localization system represents the latest advancement in breast-conserving surgery, using the only non-magnetic and non-radioactive localization technology available.
As the global leader in wire-free localization, we are proud to have made a difference in the lives of over 455,000 patients worldwide.
CHOOSE WISELY. CHOOSE SCOUT®
At Siemens Healthineers, we pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. As a leader in medical technology, we want to advance a world in which breakthroughs in healthcare create new possibilities with a minimal impact on our planet. By consistently bringing innovations to the market, we enable healthcare professionals to innovate personalised care, achieve operational excellence and transform the system of care. Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways.
Explore our portfolio at www.siemens-healthineers.co.uk
At It’s Interventional we aim to provide a complete solution for
your breast care procedures and we’re proud to offer solutions at each
touch point of the patient journey. We have one of the most comprehensive
breast solution portfolios in the UK. Our offering includes proven brands such
as the Mammotome Revolve™ Dual
Vacuum –Assisted Breast Biopsy System, a range of breast marker clips including
HydroMARK™ breast biopsy site marker, a full range of soft tissue
devices including Quick-Core® and MedOne Ultra and Mammotome Confirm™ Core
Specimen Radiography system. We also offer a range of surgery orientated
products including our range of X-Reidy, Kopans and MREye® localisation wires,
along with the Neoprobe® gamma detection device. These products, together with a comprehensive
range of accessories, service plan options and our team of product specialists
make us the reliable choice for your breast care needs.
Visit our website, itsinterventional.com for more details.
Visit us on stand
For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
A leading provider of cancer screening and diagnostic tests, Exact Sciences helps patients and health care providers make timely, informed decisions before, during, and after a cancer diagnosis. The company’s growing portfolio includes well-established brands such as Cologuard® (currently USA only) and Oncotype DX®. We serve patients in more than 90 countries and our Oncotype DX Breast Recurrence Score® test is the most commonly used genomic assay in the NHS for adjuvant chemotherapy treatment decision-making for HR-positive, HER2-negative, early breast cancer patients. To learn more please visit ExactSciences.co.uk or OncotypeDX.co.uk. You can connect with us on LinkedIn or contact our Customer Support team at 020 3031 8087 or europeansupport@exactsciences.com
At Canon Medical, enriching every life we touch is at the core of our ‘Made for Life’ philosophy. We provide effective healthcare solutions tailored to our customers’ specific needs, enhancing workflow and productivity to improve life for everyone. Our goal is to support healthcare professionals deliver optimum health outcomes for patients by prioritising performance, comfort, safety, and wellbeing. Through comprehensive educational support and efficient workflow solutions, we ensure uncompromised care that truly enriches every life we touch.
Visit the Canon Medical Systems website for more information: https://uk.medical.canon/
Micrima are transforming the detection of breast cancer for all women, making a difference to the early diagnosis of breast cancer. Micrima are passionate about making available a range of non-ionising radio wave tools, that can help in detection and risk assessment of breast cancer.
Our devices are aimed at being comfortable for the user and can be used frequently, from a much younger age, in order to detect breast cancer earlier. The whole team at Micrima are passionate about detecting breast cancer earlier, to prevent as many deaths as possible.
The Digital Screening team will be showcasing how they're working to modernise and improve breast screening technology. What is coming after NBSS? Want to play with the new system prototypes? See what's already done? On the stand: Dr Jim Steel and Vero Jermolina will be sharing demonstrations of the NBSS replacement being built and tested in collaboration with breast screening colleagues. Come along and share your feedback!
Managed and payment processed by:
KC Jones conference&events Ltd
Telephone: 01332 227773
Email: bsbr@kc-jones.co.uk